ID: ALA5094588

Max Phase: Preclinical

Molecular Formula: C6H8O8P2

Molecular Weight: 270.07

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=P(O)(O)Oc1ccccc1OP(=O)(O)O

Standard InChI:  InChI=1S/C6H8O8P2/c7-15(8,9)13-5-3-1-2-4-6(5)14-16(10,11)12/h1-4H,(H2,7,8,9)(H2,10,11,12)

Standard InChI Key:  FYZCRINOGJKXQT-UHFFFAOYSA-N

Associated Targets(Human)

Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 180 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.07Molecular Weight (Monoisotopic): 269.9694AlogP: 0.63#Rotatable Bonds: 4
Polar Surface Area: 133.52Molecular Species: ACIDHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.41CX Basic pKa: CX LogP: 0.06CX LogD: -6.25
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.59Np Likeness Score: 0.51

References

1. Whitfield H, Hemmings AM, Mills SJ, Baker K, White G, Rushworth S, Riley AM, Potter BVL, Brearley CA..  (2021)  Allosteric Site on SHIP2 Identified Through Fluorescent Ligand Screening and Crystallography: A Potential New Target for Intervention.,  64  (7.0): [PMID:33724834] [10.1021/acs.jmedchem.0c01944]

Source